ClinicalTrials.gg
CompletedNCT06688916SCI_EmbodimentUpdated Nov 10, 2026

A Comprehensive Assessment of Altered Embodiment in Individuals With Spinal Cord Injury

An observational study in Spinal Cord Injuries (SCI), sponsored by Swiss Paraplegic Research, Nottwil. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Swiss Paraplegic Research, Nottwil · Observational

How we know

Updated Nov 10, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
80
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 47 studies in Spinal Cord Injuries by Swiss Paraplegic Research, Nottwil — 8 open to participants now, 8 under way, none of them phase 3. Spinal Cord Injuries · Swiss Paraplegic Research, Nottwil.

Enrollment
3rd of 23
80 · median 50
Started
2025
with 3 others
Observational
23 of 47
2 open now
Registered
38th of 47
by date

Among the 47 studies in Spinal Cord Injuries by Swiss Paraplegic Research, Nottwil, this one is the 3rd largest by enrollment of the 23 observational ones that give a count, is one of 4 that started in 2025, is one of 23 observational ones, and was the 38th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

8 of the 47 studies in Spinal Cord Injuries by Swiss Paraplegic Research, Nottwil are open now, in 3 countries. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 47 studies in Spinal Cord Injuries by Swiss Paraplegic Research, Nottwil, or all of them as a file.
02

Study summary

Spinal cord injury (SCI) occurs when trauma or other factors damage the spinal cord, disrupting the flow of sensory information from the body to the brain. This interruption can interfere with embodiment-the body awareness and physical sensations processed by the brain-sometimes leading to a phenomenon called disembodiment.

For people with SCI, disembodiment may appear as unusual body sensations, like feeling that a limb is in a different position than it actually is. Such changes in body awareness can impact daily life, mental health, and rehabilitation outcomes.

Despite its importance, the study of embodiment in SCI remains limited. This project aims to explore how SCI alters embodiment, focusing on its specific characteristics, the effects on daily life, and the underlying brain activity as measured by functional magnetic resonance imaging (fMRI). Both people with and without SCI will participate.

Procedure: Participants will complete a single examination lasting 2 to 2.5 hours, including approximately 55 minutes in the MRI scanner (with preparation and follow-up).

03

Conditions studied

  • Spinal Cord Injuries (SCI)

Keywords

  • spinal cord injury
  • embodiment
  • bodily sensations
  • magnetic resonance imaging
  • daily life
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Individuals with spinal cord injury and healthy controls.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 60
  • Normal or corrected-to-normal visual acuity
  • German or Italian native speaker

Additional Inclusion Criteria only for individuals with SCI:

  • Diagnosis of traumatic spinal cord injury
  • Lesion level below T1 (first thoracic vertebra)
  • Time since injury >= 12 months
  • Residual sensation on the upper leg (sensory capability of 1 or higher on at least one leg in the dermatomes L2 and L3 for both light touch and pin prick).

Exclusion criteria

Exclusion Criteria for all participants:

  • Pregnancy or breastfeeding
  • Diagnosis of other psychiatric or neurological disorders (e.g. epilepsy, tumor in the central nervous system)
  • Confirmed diagnosis of alcohol and/or drug abuse with active consumption within the last 6 months
  • Confirmed diagnosis of traumatic brain injury, intended as visible changes in the brain diagnosed by a radiologist
  • Stroke
  • Inability to perform study procedures (e.g. inability to consent)

Additional Exclusion Criteria for both HC and SCI undergoing the fMRI procedure:

  • Active medical devices (e.g. cardiac pacemaker)
  • Inability to perform study procedures (e.g. claustrophobia)
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
80 participants (actual)
Patient registry
No

Groups and cohorts

  • Individuals with SCI - Behavioral assessment

    15 individuals with SCI will perform a comprehensive behavioral assessment of embodiment (see "Interventions"). A clinical assessment of sensory-motor symptoms will also be carried out.

    Behavioral: Behavioral assessment

  • Individuals with SCI - Behavioral assessment and fMRI

    25 individuals with SCI will perform a comprehensive behavioral assessment of embodiment and neural correlates of embodiment will be explored by means of an fMRI procedure (see "Interventions"). A clinical assessment of sensory-motor symptoms will also be carried out.

    Behavioral: Behavioral assessment · Behavioral: Functional Magnetic Resonance Imaging (fMRI)

  • Healthy controls - Behavioral assessment

    15 healthy controls will perform a comprehensive behavioral assessment of embodiment (see "Interventions").

    Behavioral: Behavioral assessment

  • Healthy controls - Behavioral assessment and fMRI

    25 individuals with SCI will perform a comprehensive behavioral assessment of embodiment and neural correlates of embodiment will be explored by means of an fMRI procedure (see "Interventions").

    Behavioral: Behavioral assessment · Behavioral: Functional Magnetic Resonance Imaging (fMRI)

Interventions

  • BehavioralBehavioral assessment

    A comprehensive behavioral assessment of embodiment and its effect on daily living, taking into account pain, interoception, emotions and anxiety, sleep quality, life satsfaction and cognition.

  • BehavioralFunctional Magnetic Resonance Imaging (fMRI)

    Neural mechanisms of embodiments will be explored with MRI sequences including structural MRI, resting-state and task-based fMRI of the head. The task will be a modified version of the rubber hand illusion, previously used to asess embodiment. Participants will be required to lay in the MRI with their legs bended upright and a screen placed at the level of their hips, which will show a pair of legs. The participant's leg will be stroked with a paintbrush while the image on the screen will be showing the virtual legs being stroked. Participants will be required to report how strongly they perceive the virtual legs as their own, as a measure of embodiment.

06

What researchers measure

Primary outcomes

  1. Score on the Body Feelings and Illusions questionnaire (BoFI)

    A questionnaires that assess different dimensions of embodiment and disembodiment.

    Time frame: Baseline

Secondary outcomes

  1. Brain activity

    Brain activity defined as changes in oxygen levels in the blood during the execution of the embodiment task, and at rest.

    Time frame: Baseline

  2. Strenght of the embodiment illusion

    Strenght of the embodiment illusion during the fMRI procedures, measured through a Likert scale.

    Time frame: Baseline

  3. Qualitative assessment of embodiment

    Qualitative assessment of the experience of embodiment by means of a semi-structured interview.

    Time frame: Baseline

  4. Score on the WHO Disability Assessment Scale (WHODAS-II)

    A scale that assesses activity limitation and participation restriction in the daily life due to disability.

    Time frame: Baseline

  5. Pain severity

    Intensity of pain measured on a visual analogue scale.

    Time frame: Baseline

  6. Score on the Positive and Negative Affect Schedule (PANAS)

    A scale which measures positive and negative sensations over the course of the last week.

    Time frame: Baseline

  7. Anxiety score on the Hospital Anxiety and Depression Scale (HADS)

    A scale the assesses the presence and the intensity of anxiety and depressive symptoms.

    Time frame: Baseline

  8. Depression score on the Hospital Anxiety and Depression Scale (HADS)

    A scale the assesses the presence and the intensity of anxiety and depressive symptoms.

    Time frame: Baseline

  9. Score on the Pittsburgh Sleep Quality Index

    A questionnaire assessing the quality of sleep.

    Time frame: Baseline

  10. Score on the Multidimensional Assessment of Interoceptive Awareness (MAIA)

    A questionnaire assessing interoceptive awarness.

    Time frame: Baseline

  11. Score on the Inclusion of Others in the Self test (IOS)

    A questionnaire assessing the relationship of the individual self with other entities (e.g., the body, the famiy, the society).

    Time frame: Baseline

  12. Score on the Montreal Cognitive Assessment (MoCA)

    A test assessing cognitive functions such as memory, attention, language, and executive functions.

    Time frame: Baseline

  13. Score on the Satisfaction with Life Scale (SLS)

    A scale assessing satisfaction in life.

    Time frame: Baseline

  14. Motor symptoms severity

    Motor symptoms severity (from level A to E) based on the International Standards for Neurological Classification of spinal cord injury (ISNCSCI)

    Time frame: Baseline

  15. Demographics

    Demographic information such as age, sex and education level, as well as time since injury.

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — The investigators plan to save anonymized data into public repositories. However, due to the size of the imaging data, a final decision has not yet been made.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Jul 2026, 13 months.

Of 124 non-industry observational studies under Spinal Cord Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 74. This study's 13 months is below that.

Counting every sponsor, half of 135 studies reached it within 39 months; a quarter within 16 and three quarters within 82.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion May 2026 → Jul 2026 and completion May 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2024
First posted
Nov 14, 2024
StartActual
Jun 4, 2025
Primary completionActual
Jul 30, 2026was May 2026
CompletionActual
Jul 31, 2026was May 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 10, 2026
Primary completion
May 2026→Jul 30, 2026 (actual)
Nov 10, 2026
Study completion
May 2026→Jul 31, 2026 (actual)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Recruiting→Completed
    Primary completion May 2026→Jul 30, 2026 (now actual)
    Study completion May 2026→Jul 31, 2026 (now actual)
    + 4 other changes: verification date, oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06688916
Lead sponsor
Swiss Paraplegic Research, Nottwil
Responsible party
Sponsor
First posted
Nov 14, 2024
Start date
Jun 4, 2025
Primary completion
Jul 30, 2026
Completion
Jul 31, 2026
Last update
Nov 10, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion